Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, The Lancet Oncology, 1(13), p. e11-e22, 2012

DOI: 10.1016/s1470-2045(11)70175-9

Links

Tools

Export citation

Search in Google Scholar

Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report

Journal article published in 2011 by Bossuyt Pm, C. d'Albuquerque, Fan St, Finn Rs, Lee Sg, D. Samuel, H. Schlitt, M. Schwartz, A. Shaked, M. Sherman, M. Siegler, S. Todo, C. Toso, F. Trevisani, N. Vauthey and other authors.
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Although liver transplantation is a widely accepted treatment for hepatocellular carcinoma (HCC), much controversy remains and there is no generally accepted set of guidelines. An international consensus conference was held on Dec 2–4, 2010, in Zurich, Switzerland, with the aim of reviewing current practice regarding liver transplantation in patients with HCC and to develop internationally accepted statements and guidelines. The format of the conference was based on the Danish model. 19 working groups of experts prepared evidence-based reviews according to the Oxford classifi cation, and drafted recommendations answering 19 specifi c questions. An independent jury of nine members was appointed to review these submissions and make fi nal recommendations, after debates with the experts and audience at the conference. This report presents the fi nal 37 statements and recommendations, covering assess ment of candidates for liver transplantation, criteria for listing in cirrhotic and non-cirrhotic patients, role of tumour downstaging, management of patients on the waiting list, role of living donation, and post-transplant management.